FDA Proposes Tougher Guidelines For Advisers
The U.S. Food and Drug Administration released draft guidelines Wednesday that would keep individuals with interests of over $50,000 in drug and medical device companies from participating in the agency's advisory...To view the full article, register now.
Already a subscriber? Click here to view full article